BioCorteX

London, United Kingdom · Founded 2021 · Privately Held (backing)

Operator of a biotechnology company intended to deliver effective therapeutics and de-risk the pharma pipeline by leveraging the synergy between drugs and bacteria. BioCorteX is based in London, United Kingdom and was founded in 2021. Its last reported valuation was $13.3 million in Mar 2023. It has raised $5.2 million.

Last reported valuation
$13.3M
Oct 2026
Priced at
—
Total raised
$5.2M
Last round
—

Who backs BioCorteX?

7 investors
InvestorType
Draper AssociatesVenture capital
Sofinnova PartnersVenture capital
Hoxton VenturesOther
Grow London—
Merck Digital Sciences Studio—
Ride Home Fund—
Voyagers.io—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

BioCorteX investors

7 investors are on record for BioCorteX, including Draper Associates, Sofinnova Partners, Hoxton Ventures and Grow London.

Free account
More of BioCorteX with a free account
  • ·Watch BioCorteX: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 7 firms already write checks for companies like BioCorteX. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View

BioCorteX Investors — Who Backs BioCorteX? | Premier Alternatives